🧵 3. Novo Nordisk's shares surge 17% on positive results of a study highlighting cardiovascular benefits of its weight-loss drug, Wegovy.
You are viewing a single comment's thread from:
🧵 3. Novo Nordisk's shares surge 17% on positive results of a study highlighting cardiovascular benefits of its weight-loss drug, Wegovy.